-
Rocket Companies Soars 6% In Friday Premarket As Activist Investor ValueAct Reveals New Position, Calls RKT A 'Sleeping Giant' In Early Innings
Friday, May 16, 2025 - 7:06am | 1131Read More...As ValueAct Holdings, LP. buys a fresh stake in Rocket Companies Inc. (NYSE:RKT), Andrew Left‘s Citron Research endorses the move, calling the investment a “multi-year story.” What Happened: The co-CEO and CIO of ValueAct, Mason Morfit, added 6.728 million shares worth $81.213...
-
Activist Hedge Fund ValueAct Boosts Meta Stake With $121M Bet, But CEO Morfit Supports Mark Zuckerberg's AI Vision: Here's What Investors Should Know (Updated)
Friday, November 15, 2024 - 8:41am | 752Read More...Editor’s Note: This story has been updated with a confirmation from ValueAct Holdings. ValueAct Holdings, L.P. reported holdings worth $3.9 billion in the September quarter after it disclosed major changes in its 13F filing for the third quarter of current fiscal. What Happened: One of the...
-
Disney Partners With ValueAct Capital For Strategic Counsel In Anticipation Of 2024 Shareholder Meeting
Wednesday, January 3, 2024 - 11:35am | 555Read More...In a move to fortify its strategic posture, The Walt Disney Company (NYSE:DIS) has brought onboard investment firm ValueAct Capital. The firm will provide strategic counsel and bolster Disney’s director nominees in preparation for the 2024 annual shareholder meeting. What Happened: Reuters...
-
Activist Investor ValueAct Offloads Entire Stake In Rolls-Royce: FT
Friday, August 7, 2020 - 4:56am | 347Read More...Activist investor ValueAct Capital is shedding its entire stake in Rolls-Royce Holdings plc (OTC: RYCEY), Financial Times reported late Thursday. What Happened: The California-based hedge fund, the largest stakeholder in the United Kingdom-based airplane engine company,...
-
A Look Back At ValueAct's Massive Microsoft Bet
Wednesday, August 17, 2016 - 2:07pm | 310Read More...A little more than three years after ValueAct Capital CEO Jeffrey Ubben disclosed the fund’s massive $2 billion stake in Microsoft Corporation (NASDAQ: MSFT), the stock has nearly doubled in price. The day before Ubben discussed the position at an investor conference in April of 2013,...
-
WSJ: Valeant To Oversee 'Sweeping Changes' To Its Board Of Directors
Thursday, April 28, 2016 - 8:53am | 263Read More...The Wall Street Journal reported Wednesday evening that Valeant Pharmaceuticals Intl Inc (NYSE: VRX) is set to implement "sweeping changes" to its board of directors. The Wall Street Journal, citing "people familiar with the matter," stated that five of Valeant's long-standing directors have...
-
Funds Are Running From Baidu, Valeant, Mondelez And Time Warner
Thursday, August 20, 2015 - 8:26am | 386Read More...Baidu Inc (ADR) (NASDAQ: BIDU) was one of the most unpopular stocks of the second quarter. According to an analysis of top hedge funds’ aggregate holdings and top purchases and sales from S&P Capital IQ, the Chinese-language Internet search provider was the stock institutional investors...
-
A Look At Jeffrey Ubben's Latest ValueAct Capital 13F
Wednesday, February 18, 2015 - 4:54pm | 358Read More...Jeffrey Ubben’s ValueAct Capital is a fund focused on long-term investments. It usually holds about 15 equity positions and changes only three or four of them for new ones each year. In its latest 13F filing for the fourth quarter of 2014, the fund disclosed two new purchases, five...
